Tannishtha Reya, PhD, is establishing the new Irving Cancer Drug Discovery Program, devoted to helping faculty accelerate research discoveries in their labs to the clinic.
In the last 50 years, the main approaches for treating myelodysplastic syndromes or acute myeloid leukemia have not changed. The Kousteni lab aims to change that.
Columbia Cancer congratulates Drs. Catherine Spina and Aaron Viny, recipients of a prestigious Clinical Scientist Development Award by the Doris Duke Charitable Foundation.
To stop acute myeloid leukemia, targeting neighboring bone cells may be a better strategy than directly targeting the cells that drive the cancer, suggests a new study led by Stavroula Kousteni, PhD.
Surviving cancer has driven Dr. Viny's work to uncover better, more effective cancer therapies. He joins Velocity this year to raise funds for critical cancer research and improve care.
HICCC researchers have combined a systems biology approach with machine learning to identify a new risk stratification for patients with pediatric acute myeloid leukemia (AML).
Columbia University’s Division of Hematology and Oncology welcomes new members, Andrew Lipsky, MD, and Aaron Viny, MD, MS, both assistant professors of medicine, to the leukemia group.
Adolfo Ferrando has been awarded the William Dameshek Prize for his contributions in advancing acute lymphoblastic leukemia (ALL) and T-cell acute lymphoblastic leukemia (T-ALL) research.